Botox Maker's IP Win 'Threatens Public Health,' ITC Told
Korean drugmaker Daewoong is fighting a U.S. International Trade Commission judge's finding that it stole trade secrets covering Allergan's Botox wrinkle treatment, saying the "holding that life itself can be a...To view the full article, register now.
Already a subscriber? Click here to view full article